Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI
TBI 机制和神经保护策略的生物学探究
基本信息
- 批准号:8668986
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-10-01 至 2012-09-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectAreaAxonBCL2 geneBehaviorBiochemicalBiologicalBiological AssayBlast CellBrainBrain InjuriesCCL2 geneCell SurvivalCessation of lifeChronicChronic HeadachesClinicalClosed head injuriesCraniocerebral TraumaCrush InjuryDiagnosisDiffuseDiffuse Axonal InjuryDown-RegulationEmergency SituationEventEyeFailureFunctional disorderFutureGene MutationGeneticGenetically Engineered MouseHealthHourImmunohistochemistryInflammatoryInjuryKnockout MiceKnowledgeLaboratoriesLengthLocationMedicalMilitary PersonnelModelingMolecularMood DisordersMouse StrainsMusNatural regenerationNerve CrushNerve DegenerationNerve FibersNerve RegenerationNeurocognitive DeficitNeuronsOptic NerveOptic Nerve InjuriesOutcomePathologicPathologyPatientsPeripheralPharmaceutical PreparationsPharmacotherapyPopulationProtocols documentationRecovery of FunctionRecruitment ActivityResearchResearch Project GrantsRetinalRetinal Ganglion CellsRiskRoleSecondary toSignal TransductionSimulateStagingStaining methodStainsSystemTimeTranslationsTraumaTraumatic Brain InjuryTraumatic CNS injuryVeteransWorkabstractingaxon regenerationaxonal degenerationcellular pathologyclinical practicecombatcytokinedisabilityefficacy testingexperiencegenetic technologyimprovedin vivoinjuredinnovationinnovative technologiesloss of functionmacrophagemouse modelneuroinflammationneuron lossnoveloptic nerve regenerationoutcome forecastpostnatalregenerativerepairedresearch studyresponsetooltreatment strategytrendvisual informationwhite matter
项目摘要
Project Summary/Abstract
Traumatic brain injury (TBI) is a significant health problem and a potentially catastrophic debilitating medical
emergency with a poor prognosis and the possibility of long-term disability. Blast-related and closed-head
injuries constitute the majority of TBIs occurring in the combat zone. Recent studies demonstrate that
diffuse axonal injury (DAI) is the most common pathologic feature largely accounting for the clinical
manifestations of TBI. Thus, future advancements in the diagnosis and treatment of TBI depend on our
understanding of temporal axonal pathophysiology of DAI and its role in patient outcome. However, several
factors have limited our understanding of the pathology and functional implications of DAI: (1) DAI is
extremely difficult to detect noninvasively; (2) it develops over a course of hours to days, even months, after
injury; (3) DAI is difficult to study because it involves multiple types of neurons and is diffuse and multifocal,
appearing throughout the deep and subcortical white matter.
This research project will take advantage of the optic nerve system to explore the hypothesis that an
innovative neuroprotective and regenerative approach is effective on minimizing axonal damage and
improving the morphological and functional recovery after CNS trauma. The optic nerve, which conveys
visual information from the eye to brain, contains axons originated from a single neuronal population-
retinal ganglion cells. Its peripheral location makes it an unusually accessible both structurally and
functionally. Optic nerve injury that creates axonal damage morphologically identical to that seen in the
brain offers a well-defined anatomical system that obviates many of the difficulties associated with
experiments on the brain. Moreover, using the advanced mouse genetic technology, successful full-length
optic nerve regeneration from the eye to the brain has been achieved in postnatal mice. The study
demonstrates the feasibility of limiting DAI following TBI and treating brain trauma.
To elucidate the pathology and mechanisms associated with axonal damage, especially DAI resulted from
blast force-induced TBI (bTBI), and to develop new treatment, this research plan proposes 3 specific aims:
Aim 1 is proposed to define the pathology and mechanisms of axonal damage induced by trauma and/or
TBI. Aim 2 will use advanced mouse genetic technology to elucidate the molecular signals leading to the
chronic axonal damage. Aim 3 will evaluate a novel neuroprotective and regenerative approach to minimize
axonal damage resulted from trauma. Quantification of neuron and axon damage will be carried out using
the standard protocols of immunohistochemistry and molecular and biochemical assays that have been
well-established. If the hypothesis is proven valid, an innovative technology that has strong implications for
translation into clinical practice could be developed in the near future.
项目总结/摘要
创伤性脑损伤(TBI)是一个严重的健康问题,也是一个潜在的灾难性的衰弱医疗问题。
预后不良的紧急情况和长期残疾的可能性。爆炸相关和闭头
在战区发生的创伤性脑损伤中,受伤占大多数。最近的研究表明,
弥漫性轴索损伤(DAI)是最常见的病理特征,
TBI的表现。因此,TBI诊断和治疗的未来进展取决于我们的
了解DAI的颞叶轴突病理生理学及其在患者预后中的作用。但几
这些因素限制了我们对DAI的病理和功能意义的理解:(1)DAI是一种
非常难以非侵入性地检测;(2)它在几小时到几天,甚至几个月的过程中发展,
损伤;(3)DAI难以研究,因为它涉及多种类型的神经元,并且是弥漫性和多灶性的,
出现在深层和皮层下的白色物质中。
这项研究计划将利用视神经系统来探讨假设,
创新神经保护和再生方法有效地将轴突损伤最小化,
改善中枢神经系统损伤后的形态和功能恢复。视神经负责传递
从眼睛到大脑的视觉信息,包含来自单个神经元群体的轴突,
视网膜神经节细胞它的外围位置使其在结构上和
功能上。视神经损伤,造成轴突损伤,形态学上与
大脑提供了一个明确的解剖系统,消除了许多困难,
大脑实验此外,利用先进的小鼠遗传技术,成功全长
在出生后的小鼠中已经实现了从眼睛到大脑的视神经再生。研究
证明了限制TBI后DAI和治疗脑创伤的可行性。
目的:探讨脑梗死后神经元轴突损伤,尤其是DAI的病理及机制。
冲击力诱导的TBI(bTBI),并开发新的治疗方法,本研究计划提出了3个具体目标:
目的1明确创伤和/或创伤后神经元轴突损伤的病理和机制,
创伤性脑损伤Aim 2将使用先进的小鼠遗传技术来阐明导致
慢性轴突损伤目的3将评估一种新的神经保护和再生方法,以减少
创伤导致轴突损伤。神经元和轴突损伤的定量将使用
免疫组织化学、分子和生物化学测定的标准方案,
很好的。如果这一假设被证明是有效的,那么一项创新技术将对
在不久的将来可以将其转化为临床实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dong Feng Chen其他文献
Dong Feng Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dong Feng Chen', 18)}}的其他基金
Histone and DNA methyltransferases in optic nerve regeneration
视神经再生中的组蛋白和 DNA 甲基转移酶
- 批准号:
10432811 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Histone and DNA methyltransferases in optic nerve regeneration
视神经再生中的组蛋白和 DNA 甲基转移酶
- 批准号:
10612888 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10298994 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10686336 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10715564 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10584665 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The 7th Military Vision Symposium on Ocular Readiness for Military Conflicts and Civilian Casualties
第七届军事视觉研讨会:军事冲突和平民伤亡的眼部准备
- 批准号:
10156646 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10472729 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration
视神经发育和再生生长的分子基础
- 批准号:
9113192 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Development of a Next Generation Visual Performance Assessment System for Rodents
开发下一代啮齿动物视觉表现评估系统
- 批准号:
9920144 - 财政年份:2015
- 资助金额:
-- - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant